首页 | 本学科首页   官方微博 | 高级检索  
     

顺铂化疗对下丘脑、血浆ghrelin和orexin 表达的影响
引用本文:王泽先 郭菲菲 公衍玲 孙向荣 栾晓 杨丹丹 张孟玲 徐珞. 顺铂化疗对下丘脑、血浆ghrelin和orexin 表达的影响[J]. 现代生物医学进展, 2016, 16(31): 6023-6027
作者姓名:王泽先 郭菲菲 公衍玲 孙向荣 栾晓 杨丹丹 张孟玲 徐珞
作者单位:青岛大学基础医学院病理生理学教研室;日照市五莲县人民医院;青岛科技大学化工学院
基金项目:国家自然科学基金项目(81270460,81470815,81500414,81300281);山东省优秀中青年科学家科研奖励基金资助项目(BS2014YY009);青岛市公共领域科技支撑计划(14-2-3-3-nsh)
摘    要:目的:观察顺铂化疗对下丘脑、血浆ghrelin、orexin表达和摄食量的影响。方法:Real-time PCR、ELISA法观察顺铂对大鼠下丘脑、血浆ghrelin、orexin表达及摄食量的影响;19名接受顺铂经导管动脉灌注化疗(TAI)的肝细胞患者(HCC),ELISA法检测化疗前和化疗后血浆ghrelin、orexin的变化,用直观类比标度(VAS)(0-10)评估食欲和摄食量。结果:每日腹腔注射顺铂6 mg/kg,1-5 d大鼠摄食量均显著减少(P0.05),且1-4 d血浆酰化ghrelin显著降低(P0.05),5d时浓度仍低于对照组,但无统计学意义。血浆非酰化ghrelin和总的血浆ghrelin没有明显变化(P0.05),而1-5天血浆orexin水平均明显降低(P0.05);顺铂注射1 d后,大鼠下丘脑ghreilin和orexin的mRNA表达量均显著减少(P0.05),ghrelin mRNA变化持续3 d,orexin mRNA在化疗后5 d仍低于对照组(P0.05);肝细胞癌患者化疗后1至8 d的摄食量明显降低,1 d和2 d时的血浆酰化ghrelin显著低于化疗前水平(P0.05)。3 d时逐渐恢复,化疗后3 d、4 d和7 d时血浆酰化ghrelin浓度与化疗前无统计学差异(P0.05)。血浆非酰化ghrelin和总的血浆ghrelin没有明显变化(P0.05);化疗后1~4 d时血浆orexin浓度均显著降低(P0.05),化疗后7 d时orexin基本恢复到化疗前水平(P0.05)。结论:顺铂可降低大鼠下丘脑和血浆ghrelin、orexin的mRNA表达,HCC的TAI会降低血浆酰化ghrelin、orexin、和摄食量。

关 键 词:顺铂;Orexin;Ghrelin;大鼠

Effects of Orexin on the Cisplatin-induced Pica in Rats
Abstract:Objective:To observe the effect of cisplatin on plasma ghrelin, orexin expression in the hypothalamus and the influenceof food intake.Methods:Real - time PCR and ELISA method to observe the cisplatin on rat hypothalamus, plasma ghrelin, orexinexpression and the influence of food intake; 19 cisplatin transcatheter arterial infusion chemotherapy (TAI) of liver cells (HCC) patients,ELISA method to detect plasma ghrelin chemotherapy before and after chemotherapy, the change of orexin, using visual analog scale(VAS) (0 to 10) evaluation appetite and food intake.Results:Daily intraperitoneal injection of cisplatin 6 mg/kg, 1-5 d food intake in ratswere significantly reduced (P<0.05), and 1-4 d plasma acylation ghrelin significantly reduced (P<0.05), 5 d concentration is still lowerthan the control group, but no statistical significance. Plasma ghrelin plasma of acylation ghrelin and general no significant change(P>0.05), and 1-5 days plasma orexin levels were significantly lower (P<0.05); Cisplatin injection after 1 d, rat hypothalamus ghreilin andorexin mRNA expression were significantly reduced (P<0.05), ghrelin mRNA for 3 d change, orexin mRNA in 5 d after chemotherapy isstill lower than the control group (P<0.05); Hepatocellular carcinoma (HCC) patients after chemotherapy significantly lower intake for 1to 8 d, 1 d and 2 d plasma acylation ghrelin is significantly below the level before chemotherapy (P<0.05). Returning when 3 d, 3 d, 4 dand 7 d after chemotherapy when the plasma concentration of acylation ghrelin and chemotherapy before no statistical difference (P>0.05).Plasma of acylation ghrelin and total plasma ghrelin there was no significant change (P>0.05); After chemotherapy when 1~4 d plasmaorexin concentrations were significantly lower(P<0.05), 7 d after chemotherapy when orexin basic to return to the front of the chemotherapy(P>0.05).Conclusion:Cisplatin can reduce rat hypothalamus and plasma ghrelin and orexin mRNA expression, HCC TAI lowersplasma acylation ghrelin, orexin, and food intake.
Keywords:Cisplatin   Orexin   Ghrelin   Rat
本文献已被 CNKI 等数据库收录!
点击此处可从《现代生物医学进展》浏览原始摘要信息
点击此处可从《现代生物医学进展》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号